Literature DB >> 10543761

In vitro susceptibilities of Burkholderia mallei in comparison to those of other pathogenic Burkholderia spp.

D J Kenny1, P Russell, D Rogers, S M Eley, R W Titball.   

Abstract

The in vitro antimicrobial susceptibilities of isolates of Burkholderia mallei to 16 antibiotics were assessed and compared with the susceptibilities of Burkholderia pseudomallei and Burkholderia cepacia. The antibiotic susceptibility profile of B. mallei resembled that of B. pseudomallei more closely than that of B. cepacia, which corresponds to their similarities in terms of biochemistry, antigenicity, and pathogenicity. Ceftazidime, imipenem, doxycycline, and ciprofloxacin were active against both B. mallei and B. pseudomallei. Gentamicin was active against B. mallei but not against B. pseudomallei. Antibiotics clinically proven to be effective in the treatment of melioidosis may therefore be effective for treating glanders.

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10543761      PMCID： PMC89557     

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  15 in total

1.  Development of resistance to ceftazidime and co-amoxiclav in Pseudomonas pseudomallei.

Authors:  D A Dance; V Wuthiekanun; W Chaowagul; Y Suputtamongkol; N J White
Journal:  J Antimicrob Chemother       Date:  1991-08       Impact factor: 5.790

2.  Oral fluoroquinolones for maintenance treatment of melioidosis.

Authors:  W Chaowagul; Y Suputtamongkul; M D Smith; N J White
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Sep-Oct       Impact factor: 2.184

3.  Halving of mortality of severe melioidosis by ceftazidime.

Authors:  N J White; D A Dance; W Chaowagul; Y Wattanagoon; V Wuthiekanun; N Pitakwatchara
Journal:  Lancet       Date:  1989-09-23       Impact factor: 79.321

4.  [Sensitivity of Pseudomonas to currently used antibacterial drugs].

Authors:  Iu V Antonov; V I Iliukhin; L D Popovtseva; V P Batmanov
Journal:  Antibiot Khimioter       Date:  1991-01

5.  In vitro susceptibility of Pseudomonas mallei to antimicrobial agents.

Authors:  S A Al-Izzi; L S Al-Bassam
Journal:  Comp Immunol Microbiol Infect Dis       Date:  1989       Impact factor: 2.268

6.  [Treatment of experimental glanders with combinations of sulfazine or sulfamonomethoxine with trimethoprim].

Authors:  V P Batmanov
Journal:  Antibiot Khimioter       Date:  1993 Apr-May

Review 7.  The pseudomallei group: a review.

Authors:  C Howe; A Sampath; M Spotnitz
Journal:  J Infect Dis       Date:  1971-12       Impact factor: 5.226

Review 8.  Melioidosis: the tip of the iceberg?

Authors:  D A Dance
Journal:  Clin Microbiol Rev       Date:  1991-01       Impact factor: 26.132

9.  [Sensitivity of Pseudomonas mallei to fluoroquinolones and their efficacy in experimental glanders].

Authors:  V P Batmanov
Journal:  Antibiot Khimioter       Date:  1991-09

10.  The antimicrobial susceptibility of Pseudomonas pseudomallei. Emergence of resistance in vitro and during treatment.

Authors:  D A Dance; V Wuthiekanun; W Chaowagul; N J White
Journal:  J Antimicrob Chemother       Date:  1989-09       Impact factor: 5.790
View more
  24 in total

1.  In vitro antibiotic susceptibilities of Burkholderia mallei (causative agent of glanders) determined by broth microdilution and E-test.

Authors:  H S Heine; M J England; D M Waag; W R Byrne
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

2.  Efficacy of postexposure therapy against glanders in mice.

Authors:  David M Waag
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

3.  Antibodies against In Vivo-Expressed Antigens Are Sufficient To Protect against Lethal Aerosol Infection with Burkholderia mallei and Burkholderia pseudomallei.

Authors:  Shawn M Zimmerman; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Infect Immun       Date:  2017-07-19       Impact factor: 3.441

4.  Use of Immunohistochemistry to Demonstrate In Vivo Expression of the Burkholderia mallei Virulence Factor BpaB During Experimental Glanders.

Authors:  Shawn M Zimmerman; Mackenzie E Long; Jeremy S Dyke; Tomislav P Jelesijevic; Frank Michel; Eric R Lafontaine; Robert J Hogan
Journal:  Vet Pathol       Date:  2017-11-16       Impact factor: 2.221

Review 5.  Melioidosis: epidemiology, pathophysiology, and management.

Authors:  Allen C Cheng; Bart J Currie
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

6.  Patterns of large-scale genomic variation in virulent and avirulent Burkholderia species.

Authors:  Catherine Ong; Chia Huey Ooi; Dongling Wang; Hweeling Chong; Kim Chong Ng; Fiona Rodrigues; May Ann Lee; Patrick Tan
Journal:  Genome Res       Date:  2004-11       Impact factor: 9.043

7.  Present and future therapeutic strategies for melioidosis and glanders.

Authors:  D Mark Estes; Steven W Dow; Herbert P Schweizer; Alfredo G Torres
Journal:  Expert Rev Anti Infect Ther       Date:  2010-03       Impact factor: 5.091

Review 8.  Antibiotic resistance in Burkholderia species.

Authors:  Katherine A Rhodes; Herbert P Schweizer
Journal:  Drug Resist Updat       Date:  2016-07-30       Impact factor: 18.500

9.  Experimental acute respiratory Burkholderia pseudomallei infection in BALB/c mice.

Authors:  Mark S Lever; Michelle Nelson; Anthony J Stagg; Richard J Beedham; Andrew J H Simpson
Journal:  Int J Exp Pathol       Date:  2009-02       Impact factor: 1.925

10.  Comparison of the in vitro and in vivo susceptibilities of Burkholderia mallei to Ceftazidime and Levofloxacin.

Authors:  Barbara M Judy; Gregory C Whitlock; Alfredo G Torres; D Mark Estes
Journal:  BMC Microbiol       Date:  2009-05-09       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.